drugset / Trial / NCT03341715
Metabotropic Glutamate Receptor-5 (mGlur5) Effects on Reward-Related fMRI-BOLD Activation in FHP and FHN
RandomizedCrossoverDouble-blindPrevention
Summary
The purpose of this pilot study is to evaluate the role of Mavoglurant in clarifying the neurobiology of alcoholism risk. This is a 1-site, randomized, within subjects, counterbalanced double-blind study of a single dose (200mg) of Mavoglurant and placebo.
Timeline
- Start
- 2018-06-01
- Primary completion
- 2019-11-13
- Completion
- 2019-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mavoglurant | Small molecule | 200 mg | — |
Indications
No indication recorded.